OCE Project Equity's report - FDA Oncology

OCE Project Equity’s report – FDA Oncology

FDA Oncology posted on X/Twitter:

“Download OCE Project Equity’s report analyzing diversity plan submissions in CDER oncology divisions during the first year following FDA’s April 2022 draft guidance on diversity plans for clinical trials.”

View additional information.
Source: FDA Oncology/X

cancer CDER oncology diversity diversity in clinical research FDA Oncology OCE Project Equity OncoDaily Oncology